V van Beurden
Impact in
- Oncology top 10%
- Lung Cancer Research Studies
- Neutropenia and Cancer Infections
- Drug Transport and Resistance Mechanisms
-
- Nausea and vomiting management
- Anesthesia and Pain Management
Papers in
- Oncology 11
- Neutropenia and Cancer Infections 7
- Lung Cancer Research Studies 5
- Cancer Treatment and Pharmacology 2
-
- Cancer therapeutics and mechanisms 8
- Co-authors
- Jaap Verweij (11 shared papers)M de Boer-Dennert (2 shared papers)G. Stoter (3 shared papers)Ronald de Wit (2 shared papers)Walter J. Loos (5 shared papers)Alex Sparreboom (4 shared papers)André Planting (5 shared papers)Daniel D. Von Hoff (4 shared papers)
- Journals
- European Journal of Cancer (4 papers)British Journal of Cancer (2 papers)Journal of Clinical Oncology (2 papers)Cancer Chemotherapy and Pharmacology (1 paper)PubMed (3 papers)
- Partner nations
- NetherlandsUnited States
In The Last Decade
V van Beurden
12 papers receiving 593 citations
Peers
Comparison fields: 5 of 74
- Oncology 323
- Surgery 247
- Pediatrics, Perinatology and Child Health 99
- Anesthesiology and Pain Medicine 28
- Physiology 107
Countries citing papers authored by V van Beurden
This map shows the geographic impact of V van Beurden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V van Beurden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V van Beurden more than expected).
Fields of papers citing papers by V van Beurden
This network shows the impact of papers produced by V van Beurden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V van Beurden. The network helps show where V van Beurden may publish in the future.
Co-authors
The 25 scholars most cited alongside V van Beurden, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 301 | |
| 2 | The orally administered P-glycoprotein inhibitor R101933 does not alter the plasma pharmacokinetics of docetaxel. | 2000 | 84 |
| 3 | 1998 | 56 | |
| 4 | 2000 | 56 | |
| 5 | A comparison of clinical pharmacodynamics of different administration schedules of oral topotecan (Hycamtin) | 1999 | 53 |
| 6 | Oral topotecan given once or twice daily for ten days: a phase I pharmacology study in adult patients with solid tumors. | 1998 | 34 |
| 7 | 1999 | 29 | |
| 8 | 1997 | 5 | |
| 9 | 1999 | 4 | |
| 10 | 1998 | 2 | |
| 11 | 1997 | 1 | |
| 12 | 1997 | 1 |
About V van Beurden
V van Beurden is a scholar working on Oncology, Molecular Biology, Surgery, Infectious Diseases and Organic Chemistry, having authored 12 papers that have together received 626 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (8 papers), Neutropenia and Cancer Infections (7 papers), Lung Cancer Research Studies (5 papers), Cancer Treatment and Pharmacology (2 papers), Nausea and vomiting management (2 papers), Pharmacological Effects and Toxicity Studies (1 paper), Antibiotics Pharmacokinetics and Efficacy (1 paper) and Pharmacogenetics and Drug Metabolism (1 paper). The work is most often cited by research in Oncology (323 citations), Surgery (247 citations), Pediatrics, Perinatology and Child Health (99 citations), Anesthesiology and Pain Medicine (28 citations) and Physiology (107 citations). V van Beurden has collaborated with scholars based in Netherlands and United States. Frequent co-authors include Jaap Verweij, M de Boer-Dennert, G. Stoter, Ronald de Wit, Walter J. Loos, Alex Sparreboom, André Planting, Daniel D. Von Hoff, Howard A. Burris and C J Gerrits. Their work appears in journals such as European Journal of Cancer, British Journal of Cancer, Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.